Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
Date:3/3/2009

New Technology Used to Treat Abnormal Heart Rhythms

AUSTIN, Texas, March 3 /PRNewswire/ -- On Tuesday, March 3, 2009, the Texas Cardiac Arrhythmia Institute at St. David's Medical Center became the first in the United States to utilize the long-awaited NaviStar(R) RMT ThermoCool(R) Catheter to treat abnormal heart rhythms, or arrhythmias, since the new technology received FDA approval on Friday, Feb. 27, 2009.

The NaviStar(R) RMT ThermoCool(R) Catheter for radiofrequency (RF) ablation is used with the NIOBE(R) Magnetic Navigation System, which helps steer a catheter remotely and guide ablation to targeted areas that require treatment.

An irregular rhythm in the left upper chamber of the heart or atrial fibrillation is the most common arrhythmia. Like other catheters, the NaviStar(R) RMT ThermoCool(R) Catheter uses heat to destroy abnormal heart muscle that causes atrial fibrillation. The new technology is unique because it sprays cooled saline. Physicians say it is safer and more effective than previous catheters and poses fewer risks for complications.

The NaviStar(R) RMT ThermoCool(R) Catheter maintains a temperature of no more than 42 degrees Celsius while ablation energy is being delivered to the heart tissue. Previously, the temperature at the tip of the catheter reached 65 degrees Celsius, which could cause blood clots on the heart tissue.

"The NaviStar(R) RMT ThermoCool(R) Catheter is revolutionary to the treatment of irregular heart rhythms," said Andrea Natale, M.D., F.A.C.C., F.H.S., executive director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center and the electrophysiologist who performed the procedure. "The fact that the Texas Cardiac Arrhythmia Institute is the first in the United States to employ this leading-edge technology is proof that we are on the forefront of treatment for heart arrhythmias."

The Texas Cardiac Arrhythmia Institute at St. David's Medical Center (TCAI) is a multi-million dollar international treatment, training and research institute specializing in heart rhythm disorders led by world-renowned electrophysiologist, Andrea Natale, M.D., F.A.C.C.

Arrhythmias are problems that affect the electrical system, or "wiring," of the heart muscle. They are very common and millions of people will experience an abnormal heart rhythm some time during their lives.

Atrial fibrillation (A Fib), known as the "silent killer" because it often goes unnoticed, is a disorder found in roughly 2.2 million Americans. During A Fib, the heart's two small upper chambers (the atria) quiver instead of beating effectively. Blood isn't pumped completely out of them, so it may pool and clot. If a piece of a blood clot in the atria leaves the heart and becomes lodged in an artery in the brain, a stroke results.

The American Heart Association estimates that 20 percent of all strokes result from A Fib and are usually more debilitating due to the larger size of the clots. A person with A Fib has a six-fold increased risk of stroke versus patients with normal heart rhythm. The likelihood of developing A Fib increases with age, affecting roughly three to five percent of people over age 65.

Traditionally, patients diagnosed with A Fib take blood thinning medications to prevent blood clots from forming in the heart. Current blood thinning medications require frequent monitoring and have diet and other drug interactions causing many patients to discontinue use of the medication.

In addition to Natale, the team of electrophysiologists with Texas Cardiac Arrhythmia and TCAI includes Shane M. Bailey, M.D.; J. David Burkhardt, M.D., F.A.C.C.; Robert C. Canby, M.D., F.A.C.C.; Rodney P. Horton M.D.; G. Joseph Gallinghouse, M.D.; Larry D. Price, D.O.; Javier E. Sanchez, M.D.; and Jason D. Zagrodzky, M.D.

The NaviStar(R) RMT ThermoCool(R) Catheter was created by Biosense Webster, a Johnson & Johnson Company.

For more information about the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, visit www.stdavids.com.

For more information about Texas Cardiac Arrhythmia, visit www.TCAheart.com.

    MEDIA CONTACTS:
    Kristin Marcum or Erin Ochoa
    Elizabeth Christian & Associates Public Relations
    512.472.9599


'/>"/>
SOURCE Texas Cardiac Arrhythmia Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Motor behavioral research at UH moves to prestigious Texas Medical Center
2. New Texas Study Reveals Serious Flaws in Abstinence Programs
3. Texas Association of Health Underwriters Announces 15th Annual Day at the Capitol
4. Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession
5. University of Texas engineers receive $3.2 million in National Science Foundation CAREER awards
6. Accordent Delivers Medical Lecture Capture Platform for University of Texas Health Sciences Center
7. Texas Mutual Wins National Employee Wellness Award
8. New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia
9. Texas Health Dallas New Intensivist Program Puts Critical-Care Specialists in the ICU - All the Time
10. High-tech Texas hospitals see fewer complications, lower costs, UT Southwestern researcher finds
11. Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: